IL1B and cancer: IL-1R1 antagonist (IL-1Ra) completely abolish IL-1β-induced enhancement of nociceptive neuron responses [90] and produce anti-allodynic effects in rat model of neuropathic [91, 92], inflammatory [9], and cancer pain [8, 13, 21].